Category Archives: pharmaceutical marketing
Okay, people, it’s safe to come out now. Jaan Sidorov of The Population Health Blog has delivered a presidential-politics free edition of Health Wonk Review. I’m hosting the next edition in two weeks, so this may be a short reprieve. … Continue reading
This week marks one month since ePharma Summit 2016 opened and closed. It’s a good time to reflect on a final takeaway from the conference and close my notebook. Clearly, there is more grand thinking about the future and emphasis … Continue reading
Insight from WEGO CEO Jack Barrette and REVOLUTION CEO Steve Case Epharma Summit 2016 has been over for two weeks, but the ideas generated by exciting thinkers, disruptors and innovators are still burning holes in my notebook. Upon reflection, themes … Continue reading
By Peggy Salvatore This is one of a series of blogs posted out of the ePharma Summit 2016 where pharmaceutical marketing folks talked tech for three days. The future is here. We just need to recognize it and start using … Continue reading
Louise Norris shows us in this week’s Health Wonk Review that while the ACA is a done deal, it isn’t over. Click here to read more.
This is the seventh entry in a series of blogs for ePharma Summit 2016 to explore ways the pharmaceutical industry can maximize the promise of digital health. Whether it is data collection in the electronic patient record, information in the claims data … Continue reading
Steve Anderson is seeing green at MedicareResources.org this week for his compilation of health wonkery. Read this week’s Money Changes Everything edition here.
This is the sixth entry in a series of blogs for ePharma Summit 2016 to explore ways the pharmaceutical industry can maximize the promise of digital health. How many times have you heard the term “silo” in reference to your organization? … Continue reading
Reposted from Joe Paduda, Managed Care Matters Well, that didn’t take very long… Hard as it is to believe, Health Wonk Review has been around for a decade. Yup, since way back in the DSL days, before the birth … Continue reading
And why digital health will eventually make the ban irrelevant By Peggy Salvatore This is the fourth in a series of blogs for ePharma Summit 2016 to explore ways the pharmaceutical industry can maximize the promise of digital health. I vaguely … Continue reading